SEC Filings: Google Invests $3.9 Million in 23andMe, Early Stage Biotech to Help Consumers Browse their Genome

Google Invests in Company to Help Consumers Understand and Browse Their Genome
Word from an SEC filing this afternoon that Google now holds a minority interest in 23andMe.

In May 2007, Google Inc. invested approximately $3.9 million in the Series A preferred stock financing of 23andMe, Inc., an early stage biotech company focused on helping consumers understand and browse their genome.

The filing goes on to say:

Anne Wojcicki, who is a co-founder of 23andMe and who is also a shareholder and member of the board of directors, is married to Sergey Brin, Google’s President, Technology and one of its founders. Sergey also holds approximately 35% of Google’s Class B common stock. Prior to Google’s investment in 23andMe, Sergey provided approximately $2.6 million in interim debt financing to 23andMe, which was repaid as part of this financing transaction. Genentech’s Chief Executive Officer, Arthur Levinson, is also a member of the board of directors of Google. Google’s Audit Committee reviewed and approved this transaction as part of Google’s procedures for entering into transactions with related parties.

Direct to 23andMe Web Site

Source: SEC

See Also: 23andMe, Inc. Completes Series A Financing

See Also: Google Takes Stake In Sergey’s Wife’s Biotech Company (via TechCrunch)

Comments are closed.